Dr. Sabrina Islam, MD

Dr. Islam practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Islam's NPI, 1891082590, was assigned on July 1, 2011. Dr. Islam graduated from State University of New York Downstate Medical Center in 2010. Dr. Islam holds Pennsylvania license MD459752.

Dr. Islam's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Islam's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Islam is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Islam to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Islam practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Islam's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Islam is licensed in Pennsylvania.

CMS data shows 621 Medicare services from Dr. Islam across 12 procedure codes in 2024, for 463 Medicare patients. Medicare paid $30,662 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 463 Medicare patients who saw Dr. Islam in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Islam's median patient age at 68, with 47% women.

In 2024, Dr. Islam wrote 633 Medicare Part D claims for 118 patients. 87% of them were for generic drugs. CMS names the drug for 547 of them, across 18 drugs with 11 or more claims each, at $67,695 in total drug cost. In 2023, CMS named 576 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Islam for performance year 2024, reported as part of a group. Dr. Islam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Islam, published from 2020 to 2025. 2021 was the busiest year, with 3. Dr. Islam has published most often in JACC Case Rep. Dr. Islam's most frequent co-authors are Vladimir Lakhter, DO, Riyaz Bashir, MD and Anuj Kumar Basil, MD.

Dmand AI links Dr. Islam to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Postthrombotic Syndrome and Venous Insufficiency.

CMS Open Payments shows 71 general payments to Dr. Islam from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Abbott Laboratories paid the most, $3,812.

Dr. Islam graduated from State University of New York Downstate Medical Center in 2010.